PharVision Advisers
BYRN icon

PharVision Advisers’s Byrna Technologies BYRN Stock Holding History

PharVision Advisers’s Portfolio BYRN Stock Details BYRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-12,191
Closed -$81.8K – 36
2026
Q2 		$81.8K Buy
+12,191
New +$74.9K 1.54% 32
2025
Q4 		– Sell
-18,913
Closed -$419K – 721
2025
Q3 		$419K Buy
+18,913
New +$420K 0.24% 64

Other funds holding BYRN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Malaga Cove Capital
Malaga Cove Capital Pv Estates, California $311M AUM 30.69% 1-Year Est. Return
KMWM
Keudell/Morrison Wealth Management Salem, Oregon $562M AUM 21.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Byrne Asset Management
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
MGO One Seven
MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

PharVision Advisers's BYRN Position: Q3 2026 in Review

PharVision Advisers sold out of Byrna Technologies (BYRN) in Q3 2026, closing a stake of 12,191 shares — an estimated $81.8K sold.

PharVision Advisers first reported a position in BYRN in Q3 2025 and held it in 2 quarters. The position peaked at $419K in Q3 2025. 26 funds tracked by Wall St. Rank hold BYRN as of Q3 2026.

  • PharVision Advisers reported no remaining Byrna Technologies position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,191 Byrna Technologies shares in Q3 2026, an estimated $81.8K.
  • PharVision Advisers first reported a position in Byrna Technologies in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Byrna Technologies position peaked at $419K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held Byrna Technologies as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.